NDAORALFOR SOLUTIONPriority Review
Approved
Jan 2018
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
4/8 — Partial
Priority Review
FIRVANQ KIT (vancomycin hydrochloride) by R-Pharm US is [ see microbiology ( ) ]. First approved in 2018.
Drug data last refreshed 13h ago · AI intelligence enriched 15h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FIRVANQ KIT is an oral vancomycin hydrochloride solution approved by FDA in January 2018 for treating Clostridioides difficile infections. It represents a formulation innovation on a well-established antibiotic mechanism, enabling convenient oral dosing for patients. The drug works through inhibition of bacterial cell wall synthesis, a classic mechanism for vancomycin.
Peak8.5 years to LOE
Product is at peak commercial stage with stable market presence; team size likely moderate with focus on clinical adoption and relationship management rather than new market development.
Mechanism of Action
[ see Microbiology ( ) ].
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FIRVANQ KIT positions professionals in a stable, mature market with established customer relationships and predictable revenue streams. Career growth in this role depends on driving incremental market share gains, managing competitive threats, and optimizing healthcare provider adoption rather than navigating high-risk clinical development.
Brand ManagerProduct Manager
Worked on FIRVANQ KIT at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.